Concord Tangible Asset Value from 2010 to 2026
| CCM Stock | USD 3.97 0.07 1.79% |
Tangible Asset Value | First Reported 2010-12-31 | Previous Quarter 0.0 | Current Value 0.0 | Quarterly Volatility 0.0 |
Check Concord Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Concord Medical's main balance sheet or income statement drivers, such as Interest Expense of 233.3 M, Selling General Administrative of 488.3 M or Total Revenue of 417.7 M, as well as many indicators such as Price To Sales Ratio of 0.0163, Dividend Yield of 5.83 or Days Sales Outstanding of 53.14. Concord financial statements analysis is a perfect complement when working with Concord Medical Valuation or Volatility modules.
Concord | Tangible Asset Value | Build AI portfolio with Concord Stock |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out the analysis of Concord Medical Correlation against competitors. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Will Health Care Providers & Services sector continue expanding? Could Concord diversify its offerings? Factors like these will boost the valuation of Concord Medical. Projected growth potential of Concord fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Concord Medical data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (5.50) | Revenue Per Share | Quarterly Revenue Growth (0.08) | Return On Assets | Return On Equity |
Understanding Concord Medical Services requires distinguishing between market price and book value, where the latter reflects Concord's accounting equity. The concept of intrinsic value - what Concord Medical's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Concord Medical's price substantially above or below its fundamental value.
It's important to distinguish between Concord Medical's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Concord Medical should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Concord Medical's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.